PURLs: Another option for patients with liver disease
- PMID: 20824221
- PMCID: PMC3183943
PURLs: Another option for patients with liver disease
Abstract
Currently used to treat hepatic encephalopathy, rifaximin is effective at preventing this common complication of chronic liver disease, as well.
Comment on
-
Rifaximin treatment in hepatic encephalopathy.N Engl J Med. 2010 Mar 25;362(12):1071-81. doi: 10.1056/NEJMoa0907893. N Engl J Med. 2010. PMID: 20335583 Clinical Trial.
References
-
- Bass NM, Mullen KD, Sanyal A, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med. 2010;362:1071–1081. - PubMed
-
- Riordan SM, Williams R. Treatment of hepatic encephalopathy. N Engl J Med. 1997;337:473–479. - PubMed
-
- Als-Nielsen B, Gluud LL, Gluud C. Nonabsorbable disaccharides for hepatic encephalopathy. Cochrane Database Syst Rev. 2004;(2):CD003044.. - PubMed
-
- Lawrence KR, Klee JA. Rifaximin for the treatment of hepatic encephalopathy. Pharmacotherapy. 2008;28:1019–1032. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
